Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
How Has The Genomic Cancer Panel And Profiling Market Size Shifted, And What Is the Outlook Through 2034?
There has been a significant increase in the market size of the genomic cancer panel and profiling within recent years. The market is estimated to climb from a value of $9.47 billion in 2024 to $10.28 billion in 2025, expanding at a compound annual growth rate (CAGR) of 8.6%. Factors like the growing global incidence of cancer, its growing use in clinical trials, the widening diagnostic infrastructure, growing knowledge about genetic testing, and an uptick in government-backed and research funding have contributed to the growth observed in the historic period.
The market size of genomic cancer panel and profiling is anticipated to have sturdy growth over the upcoming years. The estimated growth will reach $14.27 billion by 2029, with a compound annual growth rate (CAGR) of 8.5%. Factors contributing to this growth during the projection phase include increasing applications of liquid biopsy, growing utilization in early detection, the rise of personalized therapies, and an upswing in companion diagnostics approvals. Key trends during this period involve merging of AI and machine learning for interpreting genomic data, progress in multi-omics approaches, genomic data storage and analysis via the cloud, integration with electronic health records, and extension of next-generation sequencing (NGS) platforms.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24225&type=smp
What are the Fundamental Drivers and Innovations Shaping the Genomic Cancer Panel And Profiling Market?
The escalating occurrence of cancer is estimated to accelerate the expansion of the genomic cancer panel and profiling market. Recognized by the rapid and unregulated proliferation and dissemination of abnormal cells within the body, cancer is a malady whose increasing prevalence can be attributed to aspects like an aging population, which in turn intensifies the chances of cancer development due to a longer lifespan. Genomic cancer panels and profiling come into play in oncology to detect genetic variances and biomarkers, thus facilitating tailor-made treatment regimens while enhancing early cancer detection and its surveillance. For instance, the American Cancer Society, a non-profit organization based in the U.S., reported in January 2024 that approximately 20 million new instances of cancer had been globally reported in 2022, which resulted in about 9.7 million fatalities. These figures are primarily driven by population growth and the global burden of cancer is forecasted to escalate to 35 million cases by 2050. Consequently, the increasing incidence of cancer will fuel the expansion of the genomic cancer panel and profiling market.
How Is the Genomic Cancer Panel And Profiling Market Segmented?
The genomic cancer panel and profiling market covered in this report is segmented –
1) By Tissue Testing: Solid Tissue Testing, Liquid Tissue Testing
2) By Technology: Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR), Fluorescence In-Situ Hybridization (FISH), Immunohistochemistry (IHC), Other Technologies
3) By Cancer Panel Type: Single-Gene Panel, Multi-Gene Panel
4) By Application: Clinical, Research
5) By End User: Hospitals, Research And Academic Institutes, Clinical And Diagnostic Laboratories, Other End Users
Subsegments:
1) By Solid Tissue Testing: Biopsy Samples, Surgical Resection Samples, Formalin-Fixed Paraffin-Embedded (FFPE) Tissues, Fresh Frozen Tissues
2) By Liquid Tissue Testing: Blood, Urine, Saliva, Cerebrospinal Fluid (CSF), Other Bodily Fluids
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=24225&type=smp
Which Regions Are Driving the Next Phase of the Genomic Cancer Panel And Profiling Market Growth?
North America was the largest region in the genomic cancer panel and profiling market in 2024. The regions covered in the genomic cancer panel and profiling market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Key Trends Are Shaping the Future of the Genomic Cancer Panel And Profiling Market?
Major corporations in the genomic cancer panel and profiling industry are concentrating their resources on innovative developments like next-generation sequencers in order to enhance the precision, velocity, and inclusivity of cancer diagnostics while supporting more personalized approaches to treatment. Next-generation sequencers are cutting-edge DNA sequencing technologies that expedite exhaustive analysis of genetic matter to pinpoint mutations, variances, and other genomic characteristics. For instance, QIAGEN N.V., a biotech company out of the Netherlands, introduced its QIAseq panels specifically configured for next-generation sequencers in April 2025. These panels can efficiently scrutinize over 700 genes, with applications in both research and clinical fields, aiming to revolutionize cancer diagnostics and treatment approaches.
View the full report here:
How Is the Genomic Cancer Panel And Profiling Market Defined and What Are Its Core Parameters?
Genomic cancer panel and profiling is a molecular diagnostic technique that analyzes multiple genes simultaneously to detect genetic mutations, alterations, or biomarkers associated with cancer. Its primary purpose is to guide personalized treatment decisions, predict disease progression, and improve cancer diagnosis and monitoring.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24225
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model